Patents Assigned to Carter-Wallace, Inc.
-
Patent number: 6964959Abstract: The invention provides a method of inhibiting tumor growth in a mammal, by administering to the mammal composition containing methylol-containing compound. The composition is administered to directly contact a tumor cell at a dose sufficient to induce cell death by apoptosis.Type: GrantFiled: December 6, 2000Date of Patent: November 15, 2005Assignees: Carter Wallace, Inc., Rhode Island HospitalInventors: Paul Calabresi, James Darnowski, James Costin
-
Publication number: 20030044461Abstract: Compositions consisting essentially of carbetapentane tannate and guaifenesin which are effective when administered orally for the symptomatic relief of cough associated with respiratory tract conditions such as the common cold, bronchial asthma, acute and chronic bronchitis are disclosed.Type: ApplicationFiled: August 22, 2001Publication date: March 6, 2003Applicant: Carter-Wallace, Inc.Inventors: Phuong Grace Dang, Alexander D. D'Addio
-
Patent number: 6523540Abstract: The present invention relates to improved condoms which in addition to providing protection against the transmission of disease and pregnancy also allow for a high degree of stimulation and sensitivity during sexual intercourse. The condoms comprise thin, soft, strong polyether polyol and polyester polyol diisocyanate based polyurethane elastomers in combination with a spermicidal lubricant.Type: GrantFiled: March 12, 1999Date of Patent: February 25, 2003Assignee: Carter-Wallace, Inc.Inventor: Michael J. Harrison
-
Publication number: 20020099021Abstract: Tannate compositions consisting essentially of carbetapentane tannate and chlorpheniramine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, unproductive cough and upper respiratory tract conditions are disclosed.Type: ApplicationFiled: November 30, 2000Publication date: July 25, 2002Applicant: Carter-Wallace, Inc.Inventors: Ronald J. Leflein, Alexander D. D'Addio
-
Patent number: 6350742Abstract: The use of 4,4-methylenebis(tetrahydro-1,2,4-thiadiazine-1,2-dioxide) in treating infections of the ear.Type: GrantFiled: March 10, 1999Date of Patent: February 26, 2002Assignee: Carter-Wallace, Inc.Inventor: James C. Costin
-
Patent number: 6321751Abstract: A condom includes a plurality of intersecting spiral ribs extending in two different directional planes along at least a portion of the surface between the open and closed ends of the condom, with each rib being oriented at an angle of about 15° to the transverse axis of the condom.Type: GrantFiled: March 22, 2000Date of Patent: November 27, 2001Assignee: Carter-Wallace, Inc.Inventors: Steven R. Strauss, Richard D. Kline, Jim D. Burns, Michael J. Harrison
-
Patent number: 6319676Abstract: The invention provides an improved test cell for detecting the presence of an analyte in a liquid sample. The device has an elongate casing defining a liquid sample inlet, a reservoir volume, a test volume, and a window through the casing at the test volume. Disposed within the cell is a sample absorbent, a novel biphasic substrate and a reservoir, together capable of transporting an aqueous solution within the casing along a flow path extending from the sample inlet through the test volume and into the reservoir volume. The invention further comprises a method for detecting the presence of an analyte in a liquid sample using the device and a biphasic chromatographic material for carrying out the method.Type: GrantFiled: May 2, 1995Date of Patent: November 20, 2001Assignee: Carter Wallace, Inc.Inventors: Albert Nazareth, Mary Beth Boyle, Yea-Shun Cheng
-
Patent number: 6308708Abstract: A condom includes a plurality of intersecting spiral ribs extending in two different directional planes along at least a portion of the surface between the open and closed ends of the condom, with each rib being oriented at an angle of about 15° to the transverse axis of the condom.Type: GrantFiled: May 21, 2001Date of Patent: October 30, 2001Assignee: Carter-Wallace, Inc.Inventors: Steven R. Strauss, Richard D. Kline, Jim D. Burns, Michael J. Harrison
-
Patent number: 6306904Abstract: Tannate compositions consisting essentially of carbetapentane tannate and pyrilamine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, unproductive cough and upper respiratory tract conditions are disclosed.Type: GrantFiled: July 25, 2000Date of Patent: October 23, 2001Assignee: Carter-Wallace, Inc.Inventor: Steven A. Gordziel
-
Patent number: 6302108Abstract: There is provided spermicidal/antiviral compositions in the form of lotions, cremes, foams and gels that are non-irritating. The compositions contain an effective amount of 4,4′-methylenebis-(tetrahydro-1,2,4-thiadiazine)-1,1,1′,1′-tetraoxide as a spermicide/virucide.Type: GrantFiled: March 10, 2000Date of Patent: October 16, 2001Assignee: Carter-Wallace, IncInventor: Ralph Levine
-
Patent number: 6287597Abstract: Tannate compositions consisting essentially of pyrilamine tannate and phenylephrine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis and upper respiratory tract conditions are disclosed.Type: GrantFiled: March 12, 1999Date of Patent: September 11, 2001Assignee: Carter-Wallace, Inc.Inventor: Steven A. Gordziel
-
Patent number: 6277650Abstract: The invention is an improved single-step test device for detecting the presence of a pre-selected analyte in a urine stream. The device includes a hollow rectangular outer casing and an assay material disposed within co-joined upper and lower sections of the casing. The outer casing includes a urine inlet port; a viewing window in the upper section; at least the upper section consisting of transparent material; and may also include at least one drainage vent spaced about the urine inlet port. The assay material is a sorptive material including: a urine sample application region adjacent to, and in fluid communication with the urine inlet port; a capture region adjacent to the viewing window; and a fluid flow path for transporting a liquid sample between the urine sample application region and the analyte capture region. The flow of urine in the fluid path is observable through the transparent upper section for confirming a test is operative.Type: GrantFiled: December 31, 1998Date of Patent: August 21, 2001Assignee: Carter-Wallace, Inc.Inventors: Albert R. Nazareth, Mary Beth Boyle, Yea-Shun Cheng
-
Patent number: 6273702Abstract: Prophylactic devices are made in an inert atmosphere by cooling mandrels on which the devices are to be deposited, dipping the mandrels into a polymeric material in a solvent/carrier and a mold release agent, rotating the mandrels during and after the dipping, and evaporating the solvent after dipping. The apparatus includes an air lock between a section in which these functions are performed and a section located in an air atmosphere for removing the devices from the mandrels, followed by cleaning the mandrels for use in a subsequent production run for making devices.Type: GrantFiled: September 21, 1999Date of Patent: August 14, 2001Assignee: Carter-Wallace, Inc.Inventor: Frederick P. Sisbarro
-
Patent number: 6251896Abstract: The present invention relates to a method of treating a human infected with Crohn's disease comprising enterally administering to the individual in need of such treatment an effective amount of a composition comprising 4,4′-methylenebis-(tetrahydro-1,2,4-thiadiazine)-1,1,1′,1′-tetraoxide, commonly known as taurolidine.Type: GrantFiled: March 24, 2000Date of Patent: June 26, 2001Assignee: Carter-Wallace, Inc.Inventor: James C. Costin
-
Patent number: 6231326Abstract: Prophylactic devices are made in an inert atmosphere by cooling mandrels on which the devices are to be deposited, dipping the mandrels into a polymeric material in a solvent/carrier and a mold release agent, rotating the mandrels during and after the dipping, and evaporating the solvent after dipping. The apparatus includes an air lock between a section in which these functions are performed and a section located in an air atmosphere for removing the devices from the mandrels, followed by cleaning the mandrels for use in a subsequent production run for making devices.Type: GrantFiled: September 21, 1999Date of Patent: May 15, 2001Assignee: Carter-Wallace, Inc.Inventor: Frederick P. Sisbarro
-
Patent number: 6217815Abstract: Prophylactic devices are made in an inert atmosphere by cooling mandrels on which the devices are to be deposited, dipping the mandrels into a polymeric material in a solvent/carrier and a mold release agent, rotating the mandrels during and after the dipping, and evaporating the solvent after dipping. The apparatus includes an air lock between a section in which these functions are performed and a section located in an air atmosphere for removing the devices from the mandrels, followed by cleaning the mandrels for use in a subsequent production run for making devices.Type: GrantFiled: June 10, 1998Date of Patent: April 17, 2001Assignee: Carter-Wallace, Inc.Inventor: Frederick P. Sisbarro
-
Patent number: 6190155Abstract: A pair of opposing shoes are alternately and successively moved into and out of contact with a ring previously formed on a prophylactic device on a mandrel, whereby the mandrel or the shoes or both are moved in a direction during each time of contact of the shoes with the rolled portion of the device, for at least partially rolling the prophylactic device up toward its closed end, with the process being repeated until the prophylactic device is rolled up and off of the mandrel.Type: GrantFiled: September 21, 1999Date of Patent: February 20, 2001Assignee: Carter-Wallace, Inc.Inventors: Frederick P. Sisbarro, Harry G. Hawk
-
Patent number: 6164122Abstract: A plurality of test chambers or fixtures are operable for successively testing a plurality of condoms, respectively, in an automated manner. Each test chamber for testing a condom includes a housing containing a porous liner having an interior cavity conformed to the exterior shape of a condom to be tested, whereby a holder carrying the condom is inserted into the liner, a closed pathway for gas flow is provided between a gas port of the holder and the interior volume of the condom, for permitting the condom to be inflated with the gas, causing the exterior walls of the condom to be pushed against opposing inside walls of the liner, permitting gas passing through holes in the condom to flow through pores in walls of the liner to another gas port of the housing for detecting unacceptable holes in the condom using differential pressure techniques and/or gas tagging.Type: GrantFiled: April 21, 1999Date of Patent: December 26, 2000Assignee: Carter-Wallace, Inc.Inventors: Frederick P. Sisbarro, Glenn W. Thomsen
-
Patent number: D439969Type: GrantFiled: March 22, 2000Date of Patent: April 3, 2001Assignee: Carter-Wallace, Inc.Inventors: Steven R. Strauss, Richard D. Kline, Jim D. Burns, Michael J. Harrison
-
Patent number: D447419Type: GrantFiled: May 23, 2000Date of Patent: September 4, 2001Assignee: Carter-Wallace, Inc.Inventor: Ronald J. Jaketic